PRESS RELEASE
News
-
-
PRESS RELEASE
Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 Finance Contract
Newron Pharmaceuticals S.p.A. announces agreement with EIB to extend 2018 Finance Contract tranche repayment dates to June 28, 2028, focusing on lead drug candidate evenamide for treatment-resistant schizophrenia -
-
REGULATED PRESS RELEASE
bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
bioMérieux receives IVDR CE-marking for two BIOFIRE SPOTFIRE panels enhancing near-patient respiratory and sore throat diagnostics across Europe -
REGULATED PRESS RELEASE
bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient
bioMérieux obtient le marquage CE IVDR pour ses tests BIOFIRE® SPOTFIRE® R/STplus Panel et R/STplus Panel Mini, renforçant le diagnostic des infections respiratoires et pharyngées en Europe -
REGULATED PRESS RELEASE
Résultats annuels 2025 et nouvelle signature stratégique
-
-
-
-
PRESS RELEASE
DocMorris achieves 2025 targets – focus on profitability, growth and expansion of digital health platform
DocMorris AG achieves 2025 targets with focus on profitability, growth, and digital health platform expansion. Partnership with Google boosts AI strategy. Ludwigshafen site closure for efficiency
